Märkte
Wertpapier | Kurs ▲ | % | Buy | Sell | Kursziel | Potential |
---|---|---|---|---|---|---|
Endo International |
0,010 €
30.04.24 |
-16,67 % | 0 | 0 | - | - |
Cannabis Science Inc. |
0,011 €
22.11.19 |
- | 0 | 0 | - | - |
Lannett Co. Inc. |
0,015 €
03.05.23 |
-86,36 % | 0 | 0 | - | - |
Surgalign Holdings Inc. |
0,015 €
12.07.23 |
-39,53 % | 0 | 0 | - | - |
Teligent Inc. |
0,017 €
06.04.22 |
725,00 % | 0 | 0 | - | - |
ViewRay Inc |
0,025 €
03.08.23 |
2400,00 % | 0 | 3 | - | - |
Aravive, Inc. |
0,033 €
29.01.24 |
-16,67 % | 1 | 0 | 16,19 € | 49718,46 % |
Elite Pharmaceut. |
0,035 €
30.09.21 |
-4,11 % | 0 | 0 | - | - |
Avalo Therapeutics Inc. |
0,041 €
28.12.23 |
2,50 % | 2 | 0 | - | - |
INSYS Therapeutics Inc |
0,042 €
19.02.20 |
5,00 % | 0 | 0 | - | - |
Alliqua BioMedical Inc |
0,050 €
27.01.22 |
- | 0 | 0 | - | - |
Zosano Pharma Corp. |
0,050 €
28.10.22 |
- | 0 | 0 | - | - |
Sientra Inc. |
0,054 €
01.03.24 |
0,94 % | 0 | 0 | - | - |
CytRx Corp. |
0,056 €
17.05.23 |
- | 0 | 0 | - | - |
Advaxis Inc. |
0,059 €
23.09.22 |
- | 1 | 34 | - | - |
ContraFect Corp. |
0,059 €
08.06.23 |
- | 0 | 0 | - | - |
Ampio Pharmaceuticals Inc. |
0,060 €
07.01.23 |
- | 0 | 46 | - | - |
Melinta Therapeutics Inc. |
0,060 €
21.04.20 |
- | 0 | 0 | - | - |
Bellicum Pharmaceuticals Inc. |
0,064 €
05.03.24 |
-9,29 % | 0 | 13 | - | - |
Enzon Pharmaceuticals |
0,066 €
15.05.24 |
-0,75 % | 0 | 0 | - | - |
BioLase Inc. |
0,067 €
14.06.23 |
-5,52 % | 0 | 8 | - | - |
PhaseBio Pharmaceuticals Inc |
0,068 €
24.02.23 |
- | 0 | 0 | - | - |
Clovis Oncology Inc. |
0,077 €
03.04.23 |
- | 0 | 0 | - | - |
Super League Gaming Inc |
0,080 €
20.11.23 |
-6,54 % | 2 | 0 | 1,81 € | 2162,13 % |
Cannabics Pharmaceuticals Inc |
0,081 €
20.08.22 |
- | 0 | 0 | - | - |
Invitae Corp |
0,083 €
16.02.24 |
-78,84 % | 0 | 0 | - | - |
Otonomy Inc. |
0,083 €
14.04.23 |
- | 0 | 0 | - | - |
Heat Biologics Inc. |
0,087 €
16:58 |
16,78 % | 0 | 0 | - | - |
Arch Therapeutics Inc |
0,090 €
30.09.21 |
8,43 % | 0 | 0 | - | - |
Athersys Inc. |
0,095 €
20.11.23 |
6,99 % | 0 | 0 | - | - |